Indications
Treatment of adult patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic-hormone secretion (SIADH).
Composition
- Active substance
- tolvaptan
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Samsca
- Active substance
- tolvaptan
- ATC code
- C03XA01
- Therapeutic area
- Inappropriate ADH Syndrome
- Marketing authorisation holder
- Otsuka Pharmaceutical Netherlands B.V.
- Status
- Authorised
- EU authorisation
- 2 Aug 2009